Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance

Thomas Blankenstein1, Zhihai Qin

  • 1Max-Delbrück-Centrum for Molecular Medicine, 13092 Berlin, Germany.

Insights

Interferon-gamma-receptor (IFN-gammaR) deficiency increases susceptibility to methylcholanthrene (MCA)-induced tumors. A foreign-body reaction, not T-cell surveillance, appears to protect against MCA carcinogenesis.

Area of Science:

  • Immunology
  • Cancer Biology
  • Carcinogenesis

Background:

  • Interferon-gamma-receptor (IFN-gammaR) deficient mice show increased susceptibility to methylcholanthrene (MCA) induced tumors.
  • The role of T cells and the source of IFN-gamma in MCA carcinogenesis remain unclear.
  • Existing knowledge of cancer, immune regulation, and inflammation challenges traditional immune surveillance concepts for non-viral cancers.

Purpose of the Study:

  • To investigate the role of IFN-gammaR in methylcholanthrene (MCA)-induced tumor development.
  • To explore alternative protective mechanisms against chemical carcinogenesis beyond T-cell mediated immune surveillance.
  • To reconcile the observed phenomena with current understanding of cancer biology and inflammation.

Main Methods:

  • Comparative analysis of tumor incidence in IFN-gammaR-deficient mice versus control littermates following MCA exposure.
  • Assessment of the impact of T-cell absence on MCA-induced tumor incidence.
  • Histopathological analysis of MCA-treated tissues to identify protective mechanisms, such as foreign-body reactions.

Main Results:

  • IFN-gammaR-deficient mice exhibit higher susceptibility to MCA-induced tumors.
  • Absence of T cells did not significantly alter MCA-induced tumor incidence, suggesting T-cell independent protection.
  • A foreign-body reaction, involving encapsulation of MCA, was identified as a protective mechanism against carcinogenesis in tumor-free mice.
  • This tissue repair response may prevent DNA damage, tissue injury, and malignant transformation.

Conclusions:

  • IFN-gammaR-dependent protection against MCA carcinogenesis is distinct from T-cell mediated tumor transplantation immunity.
  • The observed protection is likely mediated by a tissue repair response (foreign-body reaction) rather than classical immune surveillance.
  • Increased tumor incidence in some immune-deficient mice may stem from opportunistic infections and chronic inflammation, not a lack of tumor recognition.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...